For two weeks in March, we queried our customers about the effects of the current IVIG reimbursement rates on their ability to provide infusion services to their IVIG patients. We heard from 537 acute and
non-acute care settings, and their responses provide a poignant perspective on the industry's current ability to meet our patients' needs.
We'd like to share the results with you:
- 14.5% of respondents have discontinued their outpatient IVIG clinics/services
- 44.5% plan to discontinue their outpatient IVIG clinics/services if reimbursement is not adequate
- 46.7% will keep their IVIG clinic/services open and absorb the loss
The results of the survey suggest that reduced reimbursement has already diminished access to services for many IVIG patients, and the unresolved reimbursement issue threatens to further eliminate services. Even facilities that plan to keep their IVIG services going at a loss cannot operate long under these financially perilous conditions. That leaves patients in a dangerous situation, struggling to maintain access to care — causing their health to deteriorate.
Long-term, the impact of reduced reimbursement is very serious, and we encourage you to
click here to share your concerns with CMS.
